Contaminants play an important role in the marketability of foods, to which dietary supplements belong. But there are not always regulated maximum levels for every food and every contaminant. Especially for botanical raw materials for use in food supplements, which are often highly processed extracts, the assessment of marketability regarding contaminants can be a challenge.

The GBA Group is continuing its international growth strategy by acquiring the Dutch company BAAT Holding B.V. (BAAT Medical), a leading provider of design and development services for medical devices. With this strategic acquisition, the GBA Group strengthens its position in the European medical device market, among other things by expanding its service portfolio in the development phase from the product idea to product development and successful market launch.

For almost three years now, we have been offering our leaders a workshop program specifically geared towards their practical need. It covers leadership topics, legal issues, HR, process management, and business basics. We celebrate the end of the program at a joint event discussing about leadership with representatives of our C-level management and exchanging ideas.

GBA Medical Device Services now has an updated GLP (Good Laboratory Practice) certificate following the successful move to a new, state-of-the-art laboratory. This means that we are still ideally positioned to meet your requirements even more flexibly, efficiently and with the highest quality standards.

Our partner Intercolab in Turkey has successfully obtained accreditation according to TS EN ISO/IEC 17020:2012!

This accreditation ensures that sampling is organised and carried out in accordance with the highest quality standards under accreditation. This ensures that reliability is guaranteed throughout the supply chain, from sampling to analysis.